T-Cell Immunotherapy Market Projected to Grow at an Annualized Rate of 86%, Predicts Roots Analysis – Business Wire (press release)
Business Wire (press release) |
T-Cell Immunotherapy Market Projected to Grow at an Annualized Rate of 86%, Predicts Roots Analysis
Business Wire (press release) Pemba Lahmo, the principal analyst, stated, “With two approved therapies and over 480 clinical/preclinical candidates, the T-cell immunotherapy pipeline has evolved significantly over the past few years. Around 40 therapies are in late-stages of … |
